Long-Term Effect of Repeated Brachytherapy in Intracoronary Brachytherapy Failed Lesions.
10.4070/kcj.2004.34.10.937
- Author:
Jang Whan BAE
1
;
Hyun Jae KANG
;
Kwang Il KIM
;
Young Seok CHO
;
Tae Jin YOUN
;
Bon Kwon KOO
;
In Ho CHAE
;
Myoung Mook LEE
;
Byung Hee OH
;
Young Bae PARK
;
Yun Shik CHOI
Author Information
1. Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Coronary disease;
Brachytherapy;
Restenosis
- MeSH:
Aneurysm;
Brachytherapy*;
Catheters;
Coronary Disease;
Exercise Test;
Follow-Up Studies;
Humans;
Thrombosis
- From:Korean Circulation Journal
2004;34(10):937-944
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: An intracoronary brachytherapy is the only approved treatment for in-stent restenosis. However, a considerable rate of restenosis occurs after a brachytherapy. Up to now, there was no long term outcome for repeated brachytherapy for these lesions. SUBJECTS AND METHODS: Eleven patients were admitted due to angina, with significant ischemic evidence in the stress test after the intracoronary brachytherapy. These patients were re-treated with a beta-emitting 188 rhenium-DTPA (diethylene triamine penta-acetic acid) filled balloon catheter system, using an identical method and radiation dose (17.6 Gy) to the initial radiation treatment. The long term angiographic and clinical outcomes of repeated brachytherapy in these patients were evaluated. RESULTS: The angiographic and clinical data of ten patients were evaluated, as 1 was lost. The follow-up period was 37.4+/-16.2 months (range, 8 to 53 months). There was no angiographic restenosis or target lesion revascularization (TLR) during the short term follow-up period (mean 6 months). but 2 restenosis (25%) occurred in the 2 year follow-up period and one other was added during the long term clinical follow-up period. All these restenosis lesions needed revascularization. These three TLRs occurred at 15, 24 and 43 months after the repeated brachytherapy. There was no death or nonfatal MI. No vascular perforation, aneurysm or late thrombosis was observed. CONCLUSION: A repeated brachytherapy for the treatment of a failed intracoronary brachytherapy lesion is safe and acceptably effective during the long term follow-up period. This modality might be considered as a therapeutic option for failed intracoronary brachytherapy lesions.
